ME Therapeutics Holdings Inc. (CSE:METX)

ME Therapeutics Holdings Ratios and Metrics

Market cap in millions CAD. Fiscal year is September - August.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	May 12, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022
Market Capitalization	270	69	-	-
Enterprise Value	268	68	-	-
Last Close Price	10.30	2.75	-	-
PB Ratio	122.90	46.94	-	-
P/TBV Ratio	122.90	46.94	-	-
Debt / Equity Ratio	0.05	-	0.08	-1.46
Quick Ratio	19.67	24.05	4.41	0.57
Current Ratio	20.27	24.45	4.52	0.59
Return on Equity (ROE)	-73.59%	-129.52%	-3327.53%	-
Return on Assets (ROA)	-46.43%	-77.65%	-157.78%	-
Return on Capital (ROIC)	-47.03%	-84.18%	-195.65%	-
Earnings Yield	-0.49%	-1.87%	-	-
Buyback Yield / Dilution	-4.95%	-55.90%	-84.08%	-

Updated Jan 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.